XML 16 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue:    
Total net revenue $ 52,380 $ 40,492
Operating expenses:    
Research and development 0 354
General and administrative 8,985 10,795
General and administrative - related party 2,700 0
Total operating expenses 11,685 11,149
Income from operations 40,695 29,343
Other (expense) income, net (3,099) 47
Interest income 391 236
Interest expense (7,657) (12,781)
Net income 30,330 16,845
Net income attributable to noncontrolling interest 749 0
Net income attributable to Innoviva stockholders $ 29,581 $ 16,845
Basic net income per share attributable to Innoviva stockholders $ 0.29 $ 0.16
Diluted net income per share attributable to Innoviva stockholders $ 0.27 $ 0.15
Shares used to compute Innoviva basic and diluted net income per share:    
Shares used to compute basic net income per share 100,604 107,487
Shares used to compute diluted net income per share 113,566 120,336
Royalty Revenue    
Revenue:    
Royalty revenue from a related party, net of amortization of capitalized fees paid to a related party of $3,456 in the three months ended March 31, 2018 and 2017 $ 52,380 $ 40,271
License    
Revenue:    
Revenue from collaborative arrangements from a related party $ 0 $ 221